THE BRITISH CARDIOVASCULAR SOCIETY
Set standards of clinical excellence for the benefit of patients; maintaining the highest standards in training, education and research; aims to be the primary source of professional advice and advocacy in the prevention, diagnosis and treatment of cardiovascular disease, and engage with government, patient groups, research councils, funding bodies and industry.
Objects
THE CHARITY'S OBJECTS ("THE OBJECTS") ARE TO UNDERTAKE OR PROMOTE WITH RESPECT TO DISEASES OF THE HEART OR CIRCULATION ALL OR ANY OF THE FOLLOWING BY SUCH MEANS AS ARE CHARITABLE AND IN EACH CASE FOR THE BENEFIT OF THE PUBLIC:1. THE ADVANCEMENT OF EDUCATION AND TRAINING AND THE PROMOTION AND EVALUATION OF BEST PRACTICE IN RELATION TO THE TREATMENT OF SUCH DISEASES;2. MEDICAL AND SCIENTIFIC RESEARCH AND TO DISSEMINATE THE USEFUL RESULTS OF SUCH RESEARCH;3. THE PROTECTION AND PRESERVATION OF HEALTH AND THE RELIEF OF SICKNESS OF PATIENTS SUFFERING FROM SUCH DISEASES.
Financial health, per its FY2025 accounts
The accounts state that the charity reported an operating surplus of £107,925 for the year ended 31 December 2025, with total income of £3,382,993. Per the trustees' report, free undesignated reserves stood at £4,893,458, which is below the stated policy target of £6,783,000 (equivalent to two years of planned operational costs). The trustees confirmed there is no material uncertainty regarding the charity's ability to continue as a going concern.
What the accounts disclose
“The policy states that free and undesignated reserves should be maintained at a level which is at least equivalent to 2 years of planned operational costs, which would be equivalent to £6,783k of undesignated reserves based on the 2026 budget.”
Policies the charity declares
- Complaints handling
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Social media policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 31/12/2025
- Volunteers: 45
- Employees paid over £60,000: 5 (£60,001–£70,000: 3; £70,001–£80,000: 1; £90,001–£100,000: 1)
Self-declared on the annual return for the financial year ending 31/12/2024
- Volunteers: 45
- Employees paid over £60,000: 2 (£70,001–£80,000: 1; £100,001–£110,000: 1)
Self-declared on the annual return for the financial year ending 31/12/2023
- Volunteers: 53
- Employees paid over £60,000: 1 (£70,001–£80,000: 1)
Structured financials (annual return, FY ending 31/12/2025)
Trustees
- David Moore
- Dr Andrew James Ludman
- Dr Damian Kelly
- Dr John Robert Paisey
- Dr Louise Buchanan
- Dr Malcolm Barratt-Johnson
- Dr Rajiv Sankaranarayanan
- Lois Isobel Whittaker
- Mr Nick Easterman
- Nasreen Janmohamed
- PROFESSOR NIKHIL PATEL
- Prof Nick Linker
- Professor Andre Ng
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £3.4m | £3.3m |
| 31/12/2024 | £3.3m | £3.3m |
| 31/12/2023 | £2.8m | £3.0m |
| 31/12/2022 | £2.8m | £2.9m |
| 31/12/2021 | £2.3m | £2.3m |
Common questions
Is THE BRITISH CARDIOVASCULAR SOCIETY financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported an operating surplus of £107,925 for the year ended 31 December 2025, with total income of £3,382,993. Per the trustees' report, free undesignated reserves stood at £4,893,458, which is below the stated policy target of £6,783,000 (equivalent to two years of planned operational costs). The trustees confirmed there is no material uncertainty regarding the charity's ability to continue as a going concern. Its FY2025 accounts were audited by Buzzacott Audit LLP.
Who funds THE BRITISH CARDIOVASCULAR SOCIETY?
Funders whose own accounts filings name THE BRITISH CARDIOVASCULAR SOCIETY as a grant recipient include BRITISH HEART FOUNDATION, HEART RESEARCH UK.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| BRITISH HEART FOUNDATION | FY2022 | £1.7m | Research |
| HEART RESEARCH UK | FY2022 | £30k | HRUK BCS 3 Month Clinical Placement Fellowship |
| HEART RESEARCH UK | FY2022 | £30k | HRUK BCS Clinical Team Placements x 2 |
Charities like this
- BRITISH CARDIOVASCULAR INTERVENTION SOCIETY
- BRITISH SOCIETY OF ENDOVASCULAR THERAPY
- BRITISH SOCIETY OF ECHOCARDIOGRAPHY
- BRITISH CARDIAC RESEARCH TRUST
- THE BRITISH ASSOCIATION FOR CARDIOVASCULAR PREVENTION AND REHABILITATION
- British Microcirculation and Vascular Biology Society
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE BRITISH CARDIOVASCULAR SOCIETY | £3.4m | — | — | unclear | — | no doubt |
| BRITISH CARDIOVASCULAR INTERVENTION SOCIETY | £484k | — | 0 | above | — | no doubt |
| BRITISH SOCIETY OF ENDOVASCULAR THERAPY | £364k | — | 0 | above | — | no doubt |
| BRITISH SOCIETY OF ECHOCARDIOGRAPHY | £1.6m | £80,001 - £90,000 | 1 | within | — | no doubt |
| BRITISH CARDIAC RESEARCH TRUST | £5k | — | 0 | unclear | — | no doubt |
| THE BRITISH ASSOCIATION FOR CARDIOVASCULAR PREVENTION AND REHABILITATION | £519k | — | 0 | unclear | — | no doubt |